Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury

Francesca Merighi; Sara De Vincentiis; Marco Onorati; Vittoria Raffa

doi:10.3791/66704

Organotypische Schnittkultur des Rückenmarks der Maus als Plattform zur Validierung der Zelltrans...

JoVE Journal
Neuroscience

This content is Free Access.

JoVE Journal Neuroscience

Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury

Organotypische Schnittkultur des Rückenmarks der Maus als Plattform zur Validierung der Zelltransplantation bei Rückenmarksverletzungen

Full Text

2,263 Views

07:37 min

April 12, 2024

DOI: 10.3791/66704-v

Francesca Merighi¹, Sara De Vincentiis¹, Marco Onorati¹, Vittoria Raffa¹

¹Department of Biology,University of Pisa

Please note that some of the translations on this page are AI generated. Click here for the English version.

Overview

This study introduces a reproducible method for generating and maintaining long-term spinal cord organotypic slices transplanted with neural stem cells. The model serves as an ex vivo platform for evaluating the efficacy of cellular replacement therapies aimed at spinal cord injury.

Key Study Components

Area of Science

Neuroscience
Regenerative medicine
Cellular therapies

Background

Addressing spinal cord injuries remains a significant challenge in neuroscience.
Current organotypic models have limited culture times, affecting their viability for research.
Previous studies showed suboptimal conditions for neural stem cell engraftment and maturation.
Improving cell replacement therapies requires better understanding of cell behavior post-transplantation.

Purpose of Study

To validate a long-term ex vivo spinal cord organotypic model for testing cellular replacement therapies.
To enhance survival, integration, and maturation of engrafted neural stem cells.
To offer a platform that reduces the need for in vivo studies in understanding cell therapies.

Methods Used

The study employed organotypic spinal cord slices as its main platform.
Neural stem cells were used as the key biological model.
Methods outlined are intended to support long-term culture of the organotypic slices.
The protocol aims to be simple, fast, and cost-effective, facilitating proof of concept studies.

Main Results

The model demonstrated improved survival and maturation rates of the grafted neural stem cells.
Integration of the transplanted cells into existing circuits was validated.
Findings suggest that the new method effectively addresses previous limitations in organotypic cultures.
These results support the potential for optimized transplantation strategies for spinal cord injuries.

Conclusions

This study presents a valuable tool for researchers developing cellular therapies for spinal cord injury.
The long-term organotypic model enhances understanding of cell behavior and therapeutic efficacy.
It may lead to better-informed strategies that reduce the need for animal testing in therapeutic research.

Frequently Asked Questions

What are the advantages of this organotypic model?

This model allows for long-term maintenance of spinal cord tissue while facilitating the study of cellular therapies, which enhances data reliability and reduces animal use.

How is the spinal cord organotypic model maintained?

The model is cultured under conditions that support the growth and maturation of neural stem cells, extending viable study periods beyond previous limitations.

What types of data are generated using this model?

Researchers can assess cell survival, integration into host circuits, and differentiation outcomes over an extended culture time.

How can this method be applied in other research areas?

The protocol can be adapted for studies involving various cellular interventions and injury models beyond spinal cord research.

Are there any limitations to this method?

While promising, the method requires further validation to ensure its applicability across different types of spinal cord injuries and therapies.

In dieser Arbeit stellen wir eine reproduzierbare Methode zur Generierung und Erhaltung von organotypischen Schnitten des Rückenmarks vor, die mit neuralen Stammzellen transplantiert wurden, als ex vivo-Modell für die Erprobung von zellulären Ersatztherapien.

Wir sind daran interessiert, einen vielversprechenden regenerativen Ansatz zur Behandlung von Rückenmarksverletzungen zu entwickeln. In diesem Artikel validieren wir das organotypische Modell des Rückenmarks für die Erprobung von Zellersatztherapien in der Rückenmarksforschung. Bisher werden organotypische Modelle des Rückenmarks zwei bis drei Wochen in vitro in Kultur gehalten.

Und Subkulturmedien sind suboptimal für die Transplantation, Differenzierung und Reifung von neuralen Stammzellen. Zellersatztherapien erfordern immer noch die Verbesserung, um die Fähigkeit der transplantierten Zellen zu verkünden, die verlorenen Schaltkreise wiederherzustellen. Mit diesem Protokoll stellen wir eine neuartige, langfristige Ex-vivo-Plattform zur Verfügung, um Probleme im Zusammenhang mit Zelltransplantationen wie Überleben, Integration und Reifungsrate der transplantierten neuralen Stammzellen anzugehen.

Diese Plattform wird für Forscher hilfreich sein, um die beste Strategie für die Zelltransplantation zu finden und die Anzahl der für die In-vivo-Validierung erforderlichen Tiere zu reduzieren. Unser Protokoll ist einfach, schnell und kostengünstig, um Proof-of-Concept- und Optimierungsstudien durchzuführen.